Inactief instrument

Officiële publicaties Galapagos NV Euronext Bruxelles

Aandelen

Geschatte realtime Tradegate Andere beurzen 17:08:22 05-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
25,12 ^EUR	0,00%		0,00%	0,00%

31/05	Galapagos, Adaptimmune gaan samen een behandeling voor hoofd-halskanker ontwikkelen	MT
30/05	Galapagos en Adaptimmune ondertekenen een klinische samenwerkingsovereenkomst met een optie om Adaptimmune's TCR T-celtherapiekandidaat, uza-cel, exclusief te licenseren	CI

1st quarter results	02/05	CO
Minutes of the general assembly	30/04	CO
Annual ESG Report	29/03	CO
Annual ESG Report	28/03	CO
Mixed general shareholder meeting	28/03	CO
Mixed general shareholder meeting	28/03	CO
Annual Report	28/03	CO
Annual Report	28/03	CO
Changes in management and corporate officers	26/03	CO
Changes in management and corporate officers	26/03	CO
Annual results	22/02	CO
Annual results	22/02	CO
Changes in management and corporate officers	06/12	CO
3rd quarter results	02/11	CO
3rd quarter results	02/11	CO
Changes in management and corporate officers	19-09-23	CO
Changes in management and corporate officers	19-09-23	CO
1st-half-year results	03-08-23	CO
Half-year report	03-08-23	CO
Half-year report	03-08-23	CO
Changes in management and corporate officers	15-06-23	CO
Changes in management and corporate officers	15-06-23	CO
Changes in management and corporate officers	12-06-23	CO
Changes in management and corporate officers	12-06-23	CO
Minutes of the general assembly	10-05-23	CO